CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment

Literals

ou:eid
- 2-s2.0-84886597555
ou:urlScopus
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84886597555&origin=inward
ou:bibtex
- @article{Dorado2013,title = {CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment},journal = {Pharmacogenetics and Genomics},year = {2013},volume = {23},number = {11},pages = {627-630},author = {Almoguera, B. and Riveiro-Alvarez, R. and Lopez-Castroman, J. and Dorado, P. and Vaquero-Lorenzo, C. and Fernandez-Piqueras, J. and Llerena, A. and Abad-Santos, F. and Baca-Garc{\'i}a, E. and Dal-R{\'e}, R. and Ayuso, C.}}
ou:urlOrcid
- http://www.scopus.com/inward/record.url?eid=2-s2.0-84886597555&partnerID=MN8TOARS
bibo:doi
- 10.1097/fpc.0b013e3283659a94
vivo:identifier
- 2013-683
dcterms:creator
- Almoguera B.
dcterms:publisher
- Pharmacogenetics and Genomics
dcterms:contributor
- Almoguera B. et al.
bibo:eissn
- 1744-6880
fabio:hasPublicationYear
- 2013
bibo:issn
- 1744-6872
ou:tipoPublicacion
- Article
dcterms:title
- CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment
bibo:page_range
- 627-630
vcard:url
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84886597555&origin=inward
bibo:volume
- 23